Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) Overlap Syndrome

Overview


Plain-Language Overview

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) Overlap Syndrome is a serious skin condition that affects the skin and mucous membranes, causing widespread redness, blistering, and peeling. It usually happens as a reaction to certain medications or infections. The condition damages the outer layer of the skin, leading to painful sores and making the body vulnerable to infections and fluid loss. It can also affect the eyes, mouth, and other organs, causing severe discomfort and complications. Because it involves a large area of skin, it requires urgent medical attention to prevent life-threatening problems.

Clinical Definition

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) Overlap Syndrome is a severe mucocutaneous reaction characterized by widespread epidermal necrosis and detachment involving 10-30% of the body surface area, representing an intermediate severity between SJS (<10% BSA) and TEN (>30% BSA). It is primarily caused by a type IV hypersensitivity reaction to drugs such as anticonvulsants, sulfonamides, and allopurinol, or less commonly infections. The pathogenesis involves cytotoxic T-cell mediated apoptosis of keratinocytes leading to full-thickness epidermal necrosis. Clinically, it presents with fever, malaise, painful erythematous macules, targetoid lesions, and mucosal erosions. The condition is a dermatologic emergency due to risks of sepsis, fluid loss, and multi-organ failure. Early recognition and differentiation from other blistering disorders are critical for prognosis.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.